It has demonstrated that cancer stem cells are preferentially sensitive to an inhibitor of AKT [8, 12] and down-regulation of the AKT pathway can enhance the cytotoxicity of TMZ [9, 13, 14]. The gene discussed is AKT1; the disease is cancer.